China's over-the-counter (OTC) drug market is enormous, with the size of 109.22 billion yuan (circa US$17.13 billion) in 2020. The market keeps gaining momentum due to the aging population and the growing healthcare awareness.  

The market access regulation on OTC drugs has eased a bit in recent years. In 2019 and 2021, China approved two pilot programs in Beijing and Henan, respectively, for importing OTC drugs through cross-border e-commerce (CBEC). Thus, CBEC emerges as a new opportunity for foreign OTC medicines to enter China.

RELATED ARTICLE: How to Sell OTC Drugs to China Through Cross-Border E-Commerce

This webinar will introduce China's OTC drug market and CBEC regulations. We recommend the article for understanding the topic better. For any related questions, please send them to contact@chemlinked.com.

1. How China Regulates OTC Drugs

2. An Overview of China's OTC Drug Market

3. China's CBEC Regulations

 3.1 Delivery Mode: 

• Bonded Warehouse (Customs Supervision Code: 1210), B2B2C;

• Direct Mail (Customs Supervision Code: 9610), B2C;

• Direct Mail, C2C

 3.2 Preferential Tax Policy

 3.3 Positive List

4. How to Establish an Online Pharmacy on a Chinese CBEC Platform

5. BaiPharm's CBEC Service for Overseas Medical Suppliers